| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 114 companies in the Pharmaceuticals industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 22, 2025 | UTHR United Therapeutics Corp | Sullivan Louis W62 | Director | Sell | 5,950 | $512.13 | $3,047,200.66 | -55.0% | +1.4% | - | |
| Dec 22, 2025 | EOLS Evolus, Inc. | Moatazedi David67 | See Remarks | Sell | 10,539 | $7.15 | $75,361.23 | -2.9% | -34.9% | - | |
| Dec 22, 2025 | UTHR United Therapeutics Corp | Benkowitz Michael47 | President And COO | Sell | 22,500 | $514.35 | $11,572,962.84 | -32.7% | +1.4% | - | |
| Dec 22, 2025 | HIMS Hims & Hers Health, Inc. | Okupe Oluyemi55 | Chief Financial Officer | Sell | 23,090 | $35.72 | $824,710.15 | -19.7% | -35.9% | - | |
| Dec 22, 2025 | BCRX Biocryst Pharmaceuticals Inc | Barnes Alane P70 | Chief Legal Officer | Sell | 21,773 | $7.65 | $166,563.45 | -5.2% | +28.8% | - | |
| Dec 19, 2025 | SUPN Supernus Pharmaceuticals, Inc. | Mottola Frank | SVP, Chief Tech. Ops. Officer | Sell | 20,000 | $50.41 | $1,008,150.00 | -39.2% | -5.1% | - | |
| Dec 19, 2025 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 10,000 | $505.38 | $5,053,778.45 | -54.3% | +1.9% | - | |
| Dec 18, 2025 | SUPN Supernus Pharmaceuticals, Inc. | Bhatt Padmanabh P.69 | Sr. VP Of Ip, CSO | Sell | 710 | $44.44 | $31,552.40 | -4.7% | +0.0% | - | |
| Dec 18, 2025 | ANIP Ani Pharmaceuticals Inc | Davis Krista45 | SVP, Chief Hr Officer | Sell | 1,622 | $82.40 | $133,652.80 | -2.7% | -10.5% | - | |
| Dec 18, 2025 | UTHR United Therapeutics Corp | Thompson Tommy G51 | Director | Sell | 910 | $500.59 | $455,533.17 | -9.7% | +4.6% | - | |
| Dec 17, 2025 | ESPR Esperion Therapeutics, Inc. | Looker Benjamin56 | General Counsel | Sell | 6,517 | $3.67 | $23,897.84 | -1.7% | -25.8% | - | |
| Dec 17, 2025 | HIMS Hims & Hers Health, Inc. | Becklund Irene | Pao | Sell | 8,411 | $36.71 | $308,767.81 | -79.8% | -28.6% | - | |
| Dec 17, 2025 | AMPH Amphastar Pharmaceuticals, Inc. | Zhou Rong59 | Senior EVP, Production Center | Sell | 9,787 | $26.20 | $256,379.27 | -6.6% | -25.2% | - | |
| Dec 17, 2025 | ESPR Esperion Therapeutics, Inc. | Koenig Sheldon L.63 | President And CEO | Sell | 48,244 | $3.67 | $177,200.21 | -3.2% | -25.8% | - | |
| Dec 17, 2025 | HIMS Hims & Hers Health, Inc. | Chi Michael | Chief Operating Officer | Sell | 13,750 | $36.71 | $504,762.50 | -4.3% | -28.6% | - | |
| Dec 17, 2025 | ESPR Esperion Therapeutics, Inc. | Halladay Benjamin | Chief Financial Officer | Sell | 7,337 | $3.67 | $26,904.78 | -1.5% | -25.8% | - | |
| Dec 17, 2025 | YCBD Cbdmd, Inc. | Crosnoe Clark R. | 10% Owner | Sell | 550,701 | $2.32 | $1,276,842.29 | -55.8% | -66.8% | - | |
| Dec 17, 2025 | HIMS Hims & Hers Health, Inc. | Autor Deborah M. | Chief Policy Officer | Sell | 7,054 | $36.71 | $258,952.34 | -53.3% | -28.6% | - | |
| Dec 17, 2025 | HIMS Hims & Hers Health, Inc. | Carroll Patrick Harrison52 | Chief Medical Officer | Sell | 10,021 | $36.71 | $367,870.91 | -5.6% | -28.6% | - | |
| Dec 16, 2025 | TEVA Teva Pharmaceutical Industries Ltd | Weiss Amir | Chief Accounting Officer | Sell | 12,300 | $30.20 | $371,504.28 | -68.5% | -2.1% | - | |
| Dec 16, 2025 | TEVA Teva Pharmaceutical Industries Ltd | Mignone Roberto | Director | Sell | 77,400 | $30.24 | $2,340,645.66 | -17.4% | -2.1% | - | |
| Dec 16, 2025 | ORGO Organogenesis Holdings Inc. | Nussdorf Glenn H70 | Director | Sell | 200,000 | $5.14 | $1,027,060.00 | -7.2% | -50.1% | - | |
| Dec 16, 2025 | UTHR United Therapeutics Corp | Rothblatt Martine A58 | Chairperson &CEO | Sell | 8,000 | $494.09 | $3,952,688.90 | -56.5% | +6.9% | - | |
| Dec 16, 2025 | NBIX Neurocrine Biosciences Inc | Norwalk Leslie V64 | Director | Sell | 6,190 | $152.78 | $945,701.91 | -31.2% | -12.7% | - | |
| Dec 15, 2025 | UTHR United Therapeutics Corp | Benkowitz Michael47 | President And COO | Sell | 22,500 | $496.30 | $11,166,721.88 | -16.6% | +6.8% | - |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.